Kensuke
Jiangsu Zheng Da Fenghai Pharmaceutical Co., Ltd. is a foreign-funded pharmaceutical enterprise jointly invested by Thailand Zheng Da Pharmaceutical Group and Jiangsu Agricultural Reclamation Group.
The company has successively won the honors of "Double Excellent Foreign Investment Enterprise", "Jiangsu High-tech Enterprise" and "AAA Credit Enterprise", and has a good reputation and reputation in the industry.
Zheng Da Fenghai pays attention to market expansion and marketing network construction, and has established a clinical research and academic promotion system with domestic medical experts. Many commercial companies have become long-term and stable partners of enterprises. The company has set up dozens of offices all over the country and has a promotion and sales team composed of hundreds of medical and marketing professionals. The company has the right to import and export foreign trade, and its raw materials and products are exported to more than ten countries and regions in the world.
Zhengda Fenghai raw materials, medicines and preparations workshops all passed the national GMP certification, dextran 40 raw materials passed the quality audit of Baxter company in the United States, and fructose raw materials were of high quality and supplied to many domestic manufacturers. The company recently launched a series of new drug preparations and widely used in clinic, which were well received by experts and patients, and other new drugs are being promoted.
Zheng Da Fenghai advocates innovative thinking, adopts the R&D concept of combining imitation and innovation in R&D strategy, and sets R&D goals that meet the market demand and the actual situation of enterprises. Every year, 3-5 new products will be put on the market to meet the needs of the market and patients.
Zhengdafenghai people always regard healthy people and Hui Ze as the highest realm of enterprise development, treat every customer with integrity, achieve mutual benefit and win-win with customers, and share the happiness of creating human health.
We look forward to working with friends from all walks of life to create a better tomorrow!
Legal Representative: Xie Bing.
Date of establishment: 1980-0 1-05.
Registered capital: USD 9,363,500.
Location: Jiangsu Province
Unified social credit code: 91320982134753235x.
Operating conditions: In operation.
Industry: manufacturing industry
Company type: limited liability company (Taiwan, Hong Kong and Macao joint venture)
English name: Jiangshu Chitai Fenghai Pharmaceutical Co., Ltd.
Staff size: 500-999 people.
Enterprise address: No.0/03, Jiankang East Road, Dafeng District, Yancheng City
Scope of business: production of large-capacity injections, tablets, hard capsules, granules and raw materials; Develop large-capacity injections, tablets, hard capsules, granules, dripping pills, bulk drugs and high-barrier plastic soft packaging; Production of high barrier plastic soft packaging bags: prepackaged foods, bulk food wholesale (except salt wholesale); Research and development of formula food for special medical use: development, consultation, transfer and promotion services of production technology of formula food for special medical use; Plastic product manufacturing; Food production (operating according to the project approved by the license); The following three licensed branches are restricted: dropping pills, small-volume injections (final sterilization, final sterilization of non-penicillin bottle injections) and freeze-dried powder injections. (Commodities subject to quota and license management and special provisions shall be managed in accordance with relevant state regulations) (Projects subject to approval according to law shall be approved by relevant departments before business activities can be carried out)